Urologix Announces Pricing of Follow-On Offering of 5.2M Shares of Common Stock at $0.75

Loading...
Loading...
Urologix®, Inc.
ULGX
, the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced the pricing of its registered follow-on firm commitment underwritten public offering of 5,200,000 shares of its common stock at a public offering price of $0.75 per share. The public offering is expected to close on or about July 5, 2012, subject to customary closing conditions. In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 780,000 shares of its common stock to cover overallotments.
Posted In: NewsOfferings
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...